Impact of the Central Blood Pressure Level in Cerebral Metabolic Aging: a 18F-FDG PET Study.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2018

Primary Completion Date

November 6, 2020

Study Completion Date

November 6, 2020

Conditions

Aging Disorder

Interventions

DEVICE

PET with a cerebral step

Positron Emission Tomography with a cerebral step before to carry out the standard Position Emission Tomography

DEVICE

Central blood pressure measurement

OTHER

Neurocognitive tests

Mini Mental State Examination, MMSE, Mini International Neuropsychiatric Interview MINI and Frontal Assessment Batery FAB

Trial Locations (1)

CHRU Nancy, Vandœuvre-lès-Nancy

All Listed Sponsors

lead

Central Hospital, Nancy, France

OTHER

NCT03345290 - Impact of the Central Blood Pressure Level in Cerebral Metabolic Aging: a 18F-FDG PET Study. | Biotech Hunter | Biotech Hunter